Moreover, we identified a de novo stopgain variant in TP53 (p.(Arg196*)) in Case-99 which is described in ClinVar to be pathogenic in association with Li-Fraumeni Syndrome (LFS). The gene discussed is TP53; the disease is Li-Fraumeni syndrome.